Shanghai Junshi Biosciences Co., Ltd. (SHJBF)

-8.37% (1Y)

Market Cap	4.12B
Revenue (ttm)	285.00M
Net Income (ttm)	-169.89M
Shares Out	n/a
EPS (ttm)	-0.17
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	150
Average Volume	553
Open	1.970
Previous Close	1.240
Day's Range	1.970 - 1.970
52-Week Range	0.952 - 2.060
Beta	0.60
RSI	n/a
Earnings Date	Aug 29, 2025

About SHJBF

Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 2,578
• Stock Exchange: OTCMKTS
• Ticker Symbol: SHJBF

Financial Performance

In 2024, SHJBF's revenue was 1.95 billion, an increase of 29.67% compared to the previous year's 1.50 billion. Losses were -1.28 billion, -43.90% less than in 2023.

Financial numbers in CNY